![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 41061 |
FusionGeneSummary for USP32_RAD51C |
![]() |
Fusion gene information | Fusion gene name: USP32_RAD51C | Fusion gene ID: 41061 | Hgene | Tgene | Gene symbol | USP32 | RAD51C | Gene ID | 84669 | 5889 |
Gene name | ubiquitin specific peptidase 32 | RAD51 paralog C | |
Synonyms | NY-REN-60|USP10 | BROVCA3|FANCO|R51H3|RAD51L2 | |
Cytomap | 17q23.1-q23.2 | 17q22 | |
Type of gene | protein-coding | protein-coding | |
Description | ubiquitin carboxyl-terminal hydrolase 32deubiquitinating enzyme 32renal carcinoma antigen NY-REN-60ubiquitin specific protease 32ubiquitin thioesterase 32ubiquitin thiolesterase 32ubiquitin-specific-processing protease 32 | DNA repair protein RAD51 homolog 3RAD51-like protein 2yeast RAD51 homolog 3 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q8NFA0 | O43502 | |
Ensembl transtripts involved in fusion gene | ENST00000300896, ENST00000592339, ENST00000393003, ENST00000586881, | ENST00000583539, ENST00000337432, ENST00000487921, ENST00000421782, | |
Fusion gene scores | * DoF score | 28 X 15 X 9=3780 | 7 X 4 X 2=56 |
# samples | 27 | 8 | |
** MAII score | log2(27/3780*10)=-3.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/56*10)=0.514573172829758 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: USP32 [Title/Abstract] AND RAD51C [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | DDR (DNA damage repair) gene involved fusion gene, retained protein feature but frameshift. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | RAD51C | GO:0006281 | DNA repair | 19451272 |
Tgene | RAD51C | GO:0006310 | DNA recombination | 19451272 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-AO-A0J5-01A | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000300896 | ENST00000583539 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
Frame-shift | ENST00000300896 | ENST00000337432 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
5CDS-3UTR | ENST00000300896 | ENST00000487921 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
5CDS-3UTR | ENST00000300896 | ENST00000421782 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3CDS | ENST00000592339 | ENST00000583539 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3CDS | ENST00000592339 | ENST00000337432 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3UTR | ENST00000592339 | ENST00000487921 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3UTR | ENST00000592339 | ENST00000421782 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
Frame-shift | ENST00000393003 | ENST00000583539 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
Frame-shift | ENST00000393003 | ENST00000337432 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
5CDS-3UTR | ENST00000393003 | ENST00000487921 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
5CDS-3UTR | ENST00000393003 | ENST00000421782 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3CDS | ENST00000586881 | ENST00000583539 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3CDS | ENST00000586881 | ENST00000337432 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3UTR | ENST00000586881 | ENST00000487921 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
intron-3UTR | ENST00000586881 | ENST00000421782 | USP32 | chr17 | 58469243 | - | RAD51C | chr17 | 56772292 | + |
Top |
FusionProtFeatures for USP32_RAD51C |
![]() |
Hgene | Tgene |
USP32 | RAD51C |
Essential for the homologous recombination (HR) pathwayof DNA repair. Involved in the homologous recombination repair(HRR) pathway of double-stranded DNA breaks arising during DNAreplication or induced by DNA-damaging agents. Part of the RAD21paralog protein complexes BCDX2 and CX3 which act at differentstages of the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage,BCDX2 seems to act downstream of BRCA2 recruitment and upstream ofRAD51 recruitment; CX3 seems to act downstream of RAD51recruitment; both complexes bind predominantly to the intersectionof the four duplex arms of the Holliday junction (HJ) and tojunction of replication forks. The BCDX2 complex was originallyreported to bind single-stranded DNA, single-stranded gaps induplex DNA and specifically to nicks in duplex DNA. The BCDX2subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependentATPase activity suggesting an involvement in early stages of theHR pathway. Involved in RAD51 foci formation in response to DNAdamage suggesting an involvement in early stages of HR probably inthe invasion step. Has an early function in DNA repair infacilitating phosphorylation of the checkpoint kinase CHEK2 andthereby transduction of the damage signal, leading to cell cyclearrest and HR activation. Participates in branch migration and HJresolution and thus is important for processing HR intermediateslate in the DNA repair process; the function may be linked to theCX3 complex. Part of a PALB2-scaffolded HR complex containingBRCA2 and which is thought to play a role in DNA repair by HR.Protects RAD51 from ubiquitin-mediated degradation that isenhanced following DNA damage. Plays a role in regulatingmitochondrial DNA copy number under conditions of oxidative stressin the presence of RAD51 and XRCC3. Contributes to DNA cross-linkresistance, sister chromatid cohesion and genomic stability.Involved in maintaining centrosome number in mitosis.{ECO:0000269|PubMed:14716019, ECO:0000269|PubMed:16215984,ECO:0000269|PubMed:16395335, ECO:0000269|PubMed:19451272,ECO:0000269|PubMed:19783859, ECO:0000269|PubMed:20413593,ECO:0000269|PubMed:23108668, ECO:0000269|PubMed:23149936}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for USP32_RAD51C |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for USP32_RAD51C |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
USP32 | CDK1, FARSA, KRT8, KRT18, KRT19, ABCD3, YWHAB, TUBA1A, SMC1A, USP6, TRIP13, ERP44, UBXN1, MRPL39, VPS35, LRRC47, USP32P2, USP4, CUL3, CAND1, RBCK1, TRIM46, RNF144A, TRIM74, ZDHHC17, RAP1B, SORT1, SYNCRIP, BAG6, FDFT1, RAB6B, TPCN2, MANSC1, ENTPD7, ALDH3B1, CD83, NME4, HSPA12A, UBC, MTNR1A, TRIM25 | RAD51C | RAD51, RAD51B, XRCC3, XRCC2, RAD51D, APP, SWSAP1, BSG, SPACA1, IL12RB1, CBWD1, TGOLN2, WNT4, THBS3, KLHL10, PTPN9, CCDC140, EFNB3, DKKL1, FAM174A, ADAMTS4, HENMT1, HELQ, PALB2, BRCA2, TRIM25 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for USP32_RAD51C |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for USP32_RAD51C |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | RAD51C | C3150659 | BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3 | 3 | CTD_human;UNIPROT |
Tgene | RAD51C | C3150653 | FANCONI ANEMIA, COMPLEMENTATION GROUP O | 2 | CTD_human;UNIPROT |
Tgene | RAD51C | C0015625 | Fanconi Anemia | 1 | CTD_human;ORPHANET |
Tgene | RAD51C | C0919267 | ovarian neoplasm | 1 | CTD_human |
Tgene | RAD51C | C1458155 | Mammary Neoplasms | 1 | CTD_human |